Skip to main content
Human Gene Therapy logoLink to Human Gene Therapy
. 2019 Sep 17;30(9):1176. doi: 10.1089/hum.2018.229.correx

Correction to: Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer by Zhang BL, Li D, Gong YL, Huang Y, Qin DY, Jiang L, Liang X, Yang X, Gou HF, Wang YS, Wei YQ, and Wang W. Hum Gene Ther. 2019;30(4):402–412. DOI: 10.1089/hum.2018.229

PMCID: PMC6762005  PMID: 31573391

In the April 2019 issue of Human Gene Therapy (vol. 30, no. 4; 402–412), the article titled Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer by Zhang BL, Li D, Gong YL, Huang Y, Qin DY, Jiang L, Liang X, Yang X, Gou HF, Wang YS, Wei YQ, and Wang W requires a correction to Figure 6C on page 409 and Figure 7C on page 410.

Representative tissue of the heart in Figure 6C was a duplicate of that in Figure 7C. Figures 6C and 7C should have appeared as:

graphic file with name fig-1.jpg

The online version of the article has been corrected to reflect this change. The authors apologize for the error.


Articles from Human Gene Therapy are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES